Dr Luca Toschi, formerly a member of PRECISION ONCOLOGY CONNECT and now a leading member of LUNG CONNECT, developed this resource with COR2ED.
Dr Luca Toschi, formerly a member of PRECISION ONCOLOGY CONNECT and now a leading member of LUNG CONNECT, developed this resource with COR2ED.
AstraZeneca, BMS, Boehringer, Ingelheim, Lilly, MSD, Pfizer and Roche.
Looking beyond the obvious mutations in non-small-cell lung cancer
Medical experts discuss current and upcoming treatment strategies to use after CDK4/6 inhibitors in patients with ER+/HER2- advanced breast cancer
Make decisions for your patient at two key stages in their journey
Experts discuss new lung cancer data at a meeting hosted by eChinaHealth and COR2ED
Share the survey with patients with lung cancer and their caregivers
Explore pre-analytical phase challenges and biomarker testing in lung cancer. Moderated by the Oncology Brothers.